TREND Community’s Report on Gout Care Strategies

Picture of Trend Community
Trend Community

PHILADELPHIA, November 09, 2023 – TREND Community, a digital health analytics company that turns the conversations of rare, chronic, and emerging disease communities into actionable insights today announced that its poster, titled “Understanding Community Perspectives on Disease Management: A Social Media Analysis of Gout Care Strategies,” will be presented at the American College of Rheumatology (ACR) conference which) will be held November 10-15, 2023, in San Diego, California. 

The poster is based on a study that leveraged TREND’s analysis of over 15,000+ posts across a private Facebook group, The Gout Support Group of America (GSGA), and 50,000 posts from a public subreddit, r/gout, both dedicated to gout. 

TREND’s proprietary analytics engine, which incorporates artificial intelligence (AI) and natural language processing (NLP), determined that among the two online gout communities, uric acid monitoring achieved the highest mean sentiment. This could suggest that gout community members tend to prefer uric acid monitoring over reactive management approaches such as prednisone. 

For the complete abstract, please visit our website.


The authors are Maurice Flurie, Monica Converse, Christopher Parker, Brian LaMoreaux,  Daniel Hernandez, N. Lawrence Edwards, Gary Ho, Kristina Davidson, E. Robert Wassman, Christopher DeFelice, and Maria Picone. 

This work was funded by Horizon Therapeutics, plc. 

For additional information about this research and/or collaborating with TREND, please contact: Maria Picone at

About TREND Community

TREND Community turns the conversations of people who have rare, chronic, and emerging diseases and their caregivers/care partners into actionable insights through our proprietary evidence-accelerator approach. Above all, we prioritize the privacy and trust of every community member. 

About Horizon Therapeutics

Horizon Therapeutics, plc is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit